Coya Therapeutics, Inc. Common Stock (COYA) — Financial Flexibility Index
Coya Therapeutics, Inc. Common Stock (COYA) has a Financial Flexibility Index of -1.44x as of March 2026. Free cash flow of $-6.21 Million (operating CF $-6.21 Million minus capex $0.00) represents -1% of total liabilities ($4.30 Million). Check strategic asset allocation of Coya Therapeutics, Inc. Common Stock to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Coya Therapeutics, Inc. Common Stock Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Coya Therapeutics, Inc. Common Stock across 6 annual periods. See Coya Therapeutics, Inc. Common Stock current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Coya Therapeutics, Inc. Common Stock (2020–2025)
Year-by-year free cash flow to debt coverage for Coya Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see COYA market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.55x | $-10.74 Million | $-10.74 Million | $6.92 Million | ▲ +28.1% |
| 2024 | -2.16x | $-10.29 Million | $-10.29 Million | $4.77 Million | ▼ -8.5% |
| 2023 | -1.99x | $-11.19 Million | $-11.19 Million | $5.63 Million | ▼ -361.2% |
| 2022 | -0.43x | $-7.24 Million | $-7.24 Million | $16.79 Million | ▲ +86.9% |
| 2021 | -3.28x | $-3.77 Million | $-3.90 Million | $1.15 Million | ▼ -274.8% |
| 2020 | -0.88x | $-391.26K | $-391.27K | $447.12K | — |